Modulation of airway epithelial cell functions by Pidotimod: NF-kB cytoplasmatic expression and its nuclear translocation are associated with an increased TLR-2 expression
© Carta et al.; licensee BioMed Central Ltd. 2013
Received: 22 January 2013
Accepted: 30 April 2013
Published: 10 May 2013
Recurrent respiratory infections are one of the most important causes of morbidity in childhood. When immune functions are still largely immature, the airway epithelium plays a primary defensive role since, besides providing a physical barrier, it is also involved in the innate and the adaptive immune responses. A study was therefore designed to evaluate in vitro whether pidotimod, a synthetic dipeptide able to stimulate the inflammatory and immune effector cells, could activate bronchial epithelial cell functions involved in response to infections.
BEAS-2B cell line (human bronchial epithelial cells infected with a replication-defective Adenovirus 12-SV40 virus hybrid) were cultured in the presence of pidotimod, with or without tumor necrosis factor (TNF)-α or zymosan to assess: a) intercellular adhesion molecule (ICAM)-1 expression, by flow cytometry; b) toll-like receptor (TLR)-2 expression and production, by immunofluorescence flow cytometry and western blotting; d) interleukin (IL)-8 release, by enzyme-linked immunosorbent assay (ELISA); e) activated extracellular-signal-regulated kinase (ERK1/2) phosphorylation and nuclear factor-kappa B (NF-kB) activation, by western blotting.
The constitutive expression of ICAM-1 and IL-8 release were significant up-regulated by TNF-α (ICAM-1) and by TNF-α and zymosan (IL-8), but not by pidotimod. In contrast, an increased TLR-2 expression was found after exposure to pidotimod 10 and 100 μg/ml (p < 0.05) and to the association pidotimod 100 μg/ml + TNF-α (p < 0.05). Western blot analysis substantiated that the constitutive TLR-2 expression was significantly increased after exposure to all the stimuli. Finally, while a remarkable inhibition of TNF-α -induced ERK1/2 phosphorylation was observed in the presence of pidotimod, both TNF-α and pidotimod were effective in inducing NF-kB protein expression in the cytoplasm and its nuclear translocation.
Through different effects on ERK1/2 and NF-kB, pidotimod was able to increase the expression of TLR-2 proteins, surface molecules involved in the initiation of the innate response to infectious stimuli. The lack of effect on ICAM-1 expression, the receptor for rhinovirus, and on IL-8 release, the potent chemotactic factor for neutrophils (that are already present in sites of infection), may represent protective functions. If confirmed in vivo, these activities may, at least in part, clarify the mechanism of action of this molecule at airway level.
KeywordsRecurrent respiratory infections Immunostimulants Toll like receptor-2 ICAM-1
Respiratory tract infections, presenting as common cold, rhinosinusitis, tonsillopharyngitis, otitis media and tracheo-bronchitis, with or without airway obstruction, are highly prevalent among young children [1–3]. These infections have not only an impact on children’s health and well-being, but also generate high medical costs and indirect costs for the family and the society [4, 5]. Indeed, on average, young children experience 4–6 upper respiratory tract infections per year , but when they grow older, the incidence of these infections decreases, probably as a result of a more mature immune defenses and improved anatomical conditions. The most common pathogens involved in the etiology of recurrent respiratory infections are human rhinoviruses (HRV), adenovirus, parainfluenza virus, respiratory syncytial virus, enterovirus, human metapneumovirus and coronavirus, in addition to influenza viruses and rhinovirus [6, 7]. A major pathogenetic role is played by rhinoviruses, the most frequent causative agents of both upper and lower respiratory tract infections in infants and young children that are able to induce a broad variety of clinical outcomes, ranging from asymptomatic infections to severe respiratory diseases requiring hospitalization [6, 8].
Being protected by a highly specialized innate and adaptative immune system, the surface of the respiratory tract acts as a selective barrier, maintaining the integrity of tissue compartments and impeding entry of inhaled majority microbial pathogens, irritants and allergens . Besides providing a physical and functional barrier to external agents, airway epithelial cells are also actively involved in initiation of the host inflammatory and immune responses through the release of early inflammatory mediators [9, 10]. Through the activation of their surface pattern recognition receptors, that detect environmental stimuli, airway epithelial cells secrete endogenous danger signals, thereby activating dendritic cells and bridging innate and adaptive immunity [9–11].
Extensive research into the role of inflammatory mediators in the pathogenesis of respiratory insufficiency syndrome (RIS), has produced evidence for increased concentrations of several mediators, such as kinins, leukotrienes, histamine, interleukins 1, 6, and 8, tumor necrosis factor (TNF)-α, and regulated by activation normal T cell expressed and secreted (RANTES) in the nasal secretions of patients with colds [12–14]. The host response mechanisms triggered by viral infection and their efficacy in protecting the host are, however, extremely complex and far from being resolved. Furthermore an exaggerated inflammatory reaction, may increase the damage at airway levels, rather than protect from infection [12–15].
Several studies have shown that atopy and attendance at large daycare are associated with more common respiratory infections during the preschool years [16, 17], while only in a minority of patients partial IgA and/or IgG subclass deficiency can be demonstrated . However, a defective (immature) inflammatory and/or immune response at airway epithelial level may also be involved .
With this background a study was designed to evaluate in vitro whether pidotimod, a synthetic dipeptide active on both innate and adaptive immunity , could modulate airway epithelial cells functions involved in the response to respiratory infections. We evaluate intercellular adhesion molecule (ICAM)-1 and toll like receptor (TLR)-2 expression, interleukin (IL)-8 release and investigate the possible involvement of the protein complex nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) and the activated extracellular-signal-regulated kinase (ERK)1/2 phosphorylation.
Materials and methods
A human bronchial epithelial cells line (BEAS-2B) (ATCC, Manassas, VA, USA), derived from human bronchial epithelium transformed by an adenovirus (12-SV40 hybrid virus) was used in all the experiments . These cells, that retain electron microscopic features of epithelial cells and show positive staining with antibodies to cytokeratin, were grown as monolayer in a 1:1 mixture of Laboratory of Human Carcinogenesis (or LHC)-9 medium (Invitrogen SRL; Milan, Italy) and RPMI 1640 medium (EuroClone; Milan, Italy).
Pidotimod (99.6% purity) was gently provided by Valeas S.p.A. (Milan, Italy). Stock standard solution was prepared in PBS at the concentration of 35 mg/ml .
Assessment of cell viability
BEAS-2B were treated with pidotimod (10, 100 μg/ml), 10 ng/ml TNF-α or 50 μg/ml zymosan used alone or in association, at different time (24 and 48 h), the percent viability was measured by trypan blue dye exclusion test (EuroClone S.p.A., Mi, Italy) . Cells were counted in a Neubauer chamber and viable cells were detected based on the ability to exclude the dye. Non-viable cells were blue due to defects in the cell membrane.
BEAS-2B cells were grown to 90% confluence in 12 well culture plate in the presence of pidotimod (10 and 100 μg/ml), 10 ng/ml TNF-α, 50 μg/ml zymosan used alone or in association, or pre-treated with pidotimod for different time and then stimulated with TNF-α or zymosan for another 24 h. For each analysis 2 × 106 cells were incubated with FITC-Conjugated mouse anti ICAM-1 (Invitrogen S.r.l., San Giuliano Milanese, Italy) and with an anti-mouse TLR-2 (Santa Cruz Biotechnology Inc, Segrate, Milan, Italy) antibody for 1 h . TLR-2 expression was detected using a goat anti-mouse antibody (Alexa Fluor488; Invitrogen). The cells were washed, resuspended in PBS and immediately analyzed with FACS Calibur flow cytometer (Becton Dickson, Milan, Italy) using Cell Quest software . Mean fluorescent intensity was compared with control staining using an irrelevant isotype-matched mouse monoclonal antibody.
BEAS-2B cells were cultured on 8-well glass Labtek slides (Nalge Nunc International) under different experimental conditions. The cells were treated with 100 μg/ml pidotimod or 10 ng/ml TNF-α used alone or in association, for 24 h. BEAS-2B cells were fixed in ice-cold methanol for 5 min. After blocking BEAS-2B were labelled with mouse anti TLR-2 Abs (TL2.1; Santa Cruz Biotechnology), then with a goat anti-mouse antibody (Alexa Fluor488; Invitrogen).
BEAS-2B cells were incubated for 24 h with 10 ng/ml TNF-α, 50 μg/ml zymosan or pidotimod (10, 100 μg/ml), in the absence or presence of TNF-α and zymosan. After the treatments the supernatant were collected and IL-8 levels were quantified by enzyme-linked immunosorbent assay (ELISA) kits (R&D Systems, Minneapolis, USA), according to the manufacturer’s instructions.
Preparation of cytoplasmic extracts for TLR-2 analysis and activated extracellular-signal-regulated kinase (ERK)1/2 analysis
For TLR-2 analysis, BEAS-2B cells were grown to 90% confluence in 24 well plates and treated with pidotimod (10, 100 μg/ml), 10 ng/ml TNF-α, 50 μg/ml zymosan, used alone or in association, for 24 h. For ERK1/2 analysis, cells were equally plated and cultured until 90% confluence and then exposed to pidotimod, TNF-α or TNF-α with pidotimod, for 5 to 60 min . After the treatments the cells were scraped and lysed with lysis buffer [20 mM Tris–HCl buffer (pH 7.4)], containing 150 mM NaCl, 1 mM EDTA, 1nM EGTA, 1 mM sodium orthovanadate, 1% (v/v) Triton X-100, 1 mM PMSF, 10 μg/ml leupeptin, and 10 μg/ml aprotinin) for 5 min on ice. The lysates were then centrifuged at 12,000 g for 5 min .
Preparation of cytoplasmic and nuclear extracts for NF-kB analysis
BEAS-2B cells were grow to 90% confluence in 6 well plates and treated with 100 μg/ml pidotimod, TNF-α or TNF-α with pidotimod for 1 h. Extracts were prepared using a method described by Leslie J. Crofford . Briefly, cells resuspended in cytoplasmic buffer (10 mM HEPES, pH 7.9, 10 mM KC1, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM dithiothreitol [DTT], and protease inhibitors) on ice for 15 minutes, after which Triton X-100 was added to a final concentration of 0.25%. Intact nuclei were pelleted by centrifugation, and the cytoplasmic extract was immediately frozen. Nuclei were resuspended in high-salt buffer (20 mM HEPES, pH 7.9, 400 mM NaCI, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, and protease inhibitors) for 15 min at 4°C. The nuclear extract was collected after centrifugation at 13,500 g for 5 min at 4°C.
Western blot analysis
The protein concentration of the lysates was measured using the Bio-Rad protein assay. Equal amounts of protein were resolved with 10% or 12% SDS-PAGE and transferred to PVDF membranes. Membranes were blotted for TLR-2 and p65 NF-kB (Santa Cruz Biotechnology), total ERK1/2 and phosphorylated ERK1/2 (Cell Signaling, Technology, Beverly, MA, USA), GAPDH (Novus Biological, Inc, Segrate, Milan, Italy), Lamin A/C (Santa Cruz Biotechnology Inc, Segrate, Milan, Italy) . After incubation with HPR-conjugated anti-rabbit o anti-mouse antibody (Cell Signaling Technology), the bands were detected using enhanced chemoluminescence (ECL, Pierce, Celbio, Italy) and relevant band intensities were quantified using a Versadoc Imaging System model 3000 (Biorad Laboratories, Hercules, CA, USA).
Statistical evaluation was performed using the statistical software package GraphPad Prism 3.02 (GraphPad Software, San Diego, CA, USA). The results were expressed as mean ± standard error of the mean (SEM) and t test or the Mann–Whitney test were used. Probability values (P < 0.05) were considered as statistically significant.
Airway epithelial cell viability
Assessment of BEAS-2B cells by trypan blue dye exclusion test showed that after 24 h incubation, cell viability > 90% and was similar in cultures containing pidotimod (10 e 100 μg/ml), zymosan, TNF-α or pidotimod plus zymosan or TNF-α (not shown). Similar results were obtained exposing BEAS-2B cells for 48 h (not shown).
ICAM-1 expression by airway epithelial cells
TLR-2 expression by airway epithelial cells
ERK1/2 pathway activation
NF-kB expression and translocation
Using the BEAS-2B human bronchial epithelial cells line we have shown that pidotimod is able to induce in vitro cellular changes potentially useful in enhancing the capability of the host to fight respiratory infections. We found that exposure of BEAS-2B cells to pidotimod had no effect on ICAM-1 expression and IL-8 release, while a detectable upregulation of TLR-2 expression was observed by fluorescence microscopy, cytofluorimetry and western blot analysis. Pidotimod was also effective in inducing a remarkable inhibition of TNF-α-induced ERK1/2 phosphorylation and, at the opposite, a significant increase in NF-kB protein expression and NF-kB nuclear translocation.
Pidotimod is a synthetic dipeptide molecule with biological and immunological activity on both the adaptive and the innate immune responses . In vitro studies, both from animal and human specimens, have demonstrated a significant activity on both the innate and the adaptive immune responses, explaining the remarkable results of the clinical studies, where reduction in the rate of recurrent infections of the upper respiratory tract has been observed [25–27].
Emerging evidence from epidemiologic, clinical and animal studies indicates that viral infections, the leading cause of respiratory morbidity in young children, is an important environmental stimulus for airway injury and remodeling, resulting in bronchial hyperreactivity, impaired lung function and, potentially, persistent asthma . The availability of PCR techniques has lead to a significant improvement in virus detection rate and shown that HRVs, principally known as the “common cold” viruses, are involved in the pathogenesis of wheezing disorders in 41-45% of young children . Approximately 90% of the different HRV serotypes known utilize, as specific receptor ICAM-1, a molecule expressed on the surface of airway epithelial cells . HRV infection upregulates ICAM-1 expression on airway epithelial cells, thus facilitating further viral attachment and entry . Besides being a major receptor for HRVs, ICAM-1 is also involved in the transmigration across airway epithelial monolayers of neutrophils and their activation , and in disorders characterized by neutrophil-mediated acute lung injury . Therefore the observation that in our experimental model pidotimod did not increase the constitutive or the TNF-α -induced ICAM-1 expression may be interpreted as a “protective function”, to avoid enhanced susceptibility to human HRV and neutrophil-mediated damage to the airway surface. A similar interpretation can be made for the results on IL-8 release.
IL-8 is a powerful chemotactic and paracrine mediator for neutrophils, and infiltration of activated neutrophils play a key role in pulmonary inflammation and oxidative injury , a characteristic feature of respiratory viral infections [35, 36].
On the contrary, pidotimod enhanced the constitutive TLR-2 expression, raising questions on the activity of pidotimod on airway epithelial cells. The expression of surface molecules (such as ICAM-1 and TLR-2) is regulated not only by different stimuli [31, 37, 38] but also by dissimilar intracellular pathways that may be triggered by the same stimulus [38–41]. An example is the activity of IFN-γ, able to have opposite effects on ICAM-1 and TLR-2 expression (up- and down-regulation, respectively) on different cell types [37, 38, 42]. The characteristics of pidotimod, to be able to regulate differently the expression of surface molecules has already been demonstrated by Gourgiotis D. and co-workers . Using blood mononuclear cells, isolated from atopic asthmatic and normal children, they showed that through unknown intracellular mechanisms pidotimod downregulated the expression of CD30 induced by phytohaemoagglutinin but had no effect on human leukocyte antigen (HLA)-DR molecules .
TLRs are a class of proteins that play a key role in the innate immune system, recognizing structurally conserved molecules derived from microbes . TLRs are a type of pattern recognition receptor and recognize molecules that are broadly shared by pathogens but distinguishable from host molecules, collectively referred to pathogen-associated molecular patterns (PAMPs). Of the ten mammalian TLR proteins identified thus far, TLR-2 seems to be the least discriminating, since it recognizes many bacterial, fungal, viral, and certain endogenous substances [44, 45]. Recognition of PAMPs results in internalization and phagocytosis of bound molecules and in cellular activation with release of cytokines, chemokines and various interleukins [44, 45]. Cytokines participating in this “nonspecific” immune defense include various interleukins, such as TNF-α, IL-1α, IL-1β, IL-6, IL-8 and IL-12. PAMPs-TLR interactions on the surface of the cells are sufficient to activate the Ca2+ fluxes associated with induction of NF-kB in the airway . Recent studies have implicated TLR, and especially TLR-2 and TLR-4, as sentinel receptors able to signaling the interaction of the host cells with bacterial pathogens via an NF-kB-mediated pathway . Interestingly, using murine macrophages it was shown that TLR-2 mRNA may be induced after bacterial infection with the involvement of several cytokines, including IL-1 α, and GM-CSF, but that NF-kB is necessary for maximal TLR-2 transcription , further underlining the tight connections between NF-kB and TLR-2.
The different effects of pidotimod on BEAS-2B cells here reported may be at least partially explained by the opposite effects on some cell functions produced by ERK1/2 phosphorylation or NF-kB activation.
Extracellular-signal-regulated kinases (ERKs) or classical mitogen-activated protein (MAP) kinases are widely expressed protein kinase intracellular signalling molecules that are engaged in the regulation of meiosis, mitosis, but also in several post mitotic functions, including activities involved in inflammatory and defense processes [49, 50]. These include opposite effects on ICAM-1 and TLR-2 expression. In agreement with our results on BEAS-2B cells, stimulation of ERK1/2 phosphorylation by cysteinyl leukotriene D4 resulted in an increased ICAM-1 expression by 16HBE bronchial epithelial cells, associated with enhanced eosinophil adhesion . In contrast, inhibition of ERK1/2 phosphorylation  by up-regulation of MAP kinase phosphatase-1 by glucocorticoids increased TLR-2 expression by HeLa epithelial cells.
NF-kB is a protein complex, found in almost all animal cell types, that controls DNA transcription and is involved in cellular responses to a variety of stimuli such including bacterial or viral antigens [53, 54]. NF-kB plays a key role in regulating a quick immune response to infections because it belongs to the category of “rapid-acting” primary transcription factors, i.e. present in cells in an inactive state and not requiring new protein synthesis to be activated and is involved in the regulation of reactive oxygen species, cytokines and adhesion molecules production [54–57].
The identification of TLRs as specific pattern recognition molecules and the finding that, not only their expression is regulated by NF-kB , but also that TLR stimulation leads to NF-kB activation has improved our understanding on both the innate and the adaptive immune responses to infections.
Surprisingly, NF-kB activation induced by pidotimod did not result in an increase in IL-8 release. However, in human airway epithelial cell cultures and in mice inhibition of ERK1/2 phosphorylation suppress IL-8 production induced by exposure to sub toxic doses of cadmium . Moreover, other transcriptional factors are involved in IL-8 production and release, including activator protein 1 (AP-1), and signal transducer and activator of transcription proteins (STAT) [59, 60]. Rather than pidotimod, elevated intracellular levels of reactive oxygen species (ROS) in lung epithelial cells can activate these pathways [60, 61]. Therefore, upstream of these transcriptional factors, ROS-sensitive signaling pathways, including mitogen-activated protein kinases and protein kinase C, may be involved in the increase in inflammatory gene activation [56, 57].
We have shown that pidotimod, a synthetic dipeptide used in the prevention of recurrent respiratory infection in children, is able to modulate airway epithelial cells functions involved in host-virus possibly through NF-kB activation. The obvious limitation of the study is that the experiments here reported were obtained in a human cell line. If confirmed in vivo, these activities may, at least in part, clarify the mechanism of action of this molecule at airway level.
Respiratory insufficiency syndrome
Tumor necrosis factor-α
Regulated by activation normal T cell expressed and secreted
Intercellular adhesion molecule-1
Nuclear factor-kappa B
Enzyme-linked immunosorbent assay
Human leukocyte antigen-DR
Pathogen-associated molecular pattern
- MAP kinase:
Mitogen-activated protein kinase
Signal transducer and activator of transcription proteins
Reactive oxygen species.
The authors thank Annalisa Firenze provided technical help and writing assistance.
Sources of funding
This research was funded by Ricerca Corrente, Italian Ministry of Health, Rome, Italy. Valeas S.p.A., Milan financed the study related to this manuscript, including the article-processing charge.
- Wald ER, Guerra N, Byers C: Upper respiratory tract infections in young children: duration of and frequency of complications. Pediatrics. 1991, 87: 129-133.PubMedGoogle Scholar
- Harsten G, Prellner K, Heldrup J, Kalm O, Kornfalt R: Acute respiratory-tract infections in children. A 3-year follow-up from birth. Acta Paediatr Scand. 1990, 79: 402-409. 10.1111/j.1651-2227.1990.tb11484.x.View ArticlePubMedGoogle Scholar
- Benediktsdottir B: Upper airway infections in preschool children- frequency and risk factors. Scand J Prim Health Care. 1993, 11: 197-201. 10.3109/02813439308994830.View ArticlePubMedGoogle Scholar
- Banz K, Schwicker D, Thomas AM: Economic evaluation of immunoprophylaxis in children with recurrent ear, nose and throat infections. PharmacoEconomics. 1994, 6: 464-477. 10.2165/00019053-199406050-00008.View ArticlePubMedGoogle Scholar
- Cohen R, Just J, Koskas M, Bingen E, Boucherat M, Bourrillon A, Foucaud P, François M, Garnier JM, Guillot M, Ployet MJ, Schlemmer C, Gaudelus J: Recurrent respiratory tract infections: how should we investigate and treat?. Arch Pediatr. 2005, 12: 183-190. 10.1016/j.arcped.2004.11.013.View ArticlePubMedGoogle Scholar
- Heikkinen T, Järvinen A: The common cold. Lancet. 2003, 361: 51-59. 10.1016/S0140-6736(03)12162-9.View ArticlePubMedGoogle Scholar
- Principi N, Bosis S, Esposito S: Human metapneumovirus in paediatric patients. Clin Microbiol Infect. 2006, 12: 301-308. 10.1111/j.1469-0691.2005.01325.x.View ArticlePubMedGoogle Scholar
- Kieninger E, Fuchs O, Latzin P, Frey U, Regamey N: Rhinovirus infections in infancy and early childhood. Eur Respir J. 2012, Epub ahead of printGoogle Scholar
- Rennard SI, Romberger DJ, Sisson JH, Von Essen SG, Rubinstein I, Robbins RA, Spurzem JR: Airway epithelial cells: functional roles in airway disease. Am J Respir Crit Care Med. 1994, 150 (5 Pt 2): S27-S30.View ArticlePubMedGoogle Scholar
- Sacco O, Silvestri M, Sabatini F, Sale R, Defilippi AC, Rossi GA: Epithelial cells and fibroblasts: structural repair and remodelling in the airways. Paediatr Respir Rev. 2004, 5 (Suppl A): S35-S40.View ArticlePubMedGoogle Scholar
- Lambrecht BN, Hammad H: The airway epithelium in asthma. Nat Med. 2012, 18: 684-692. 10.1038/nm.2737.View ArticlePubMedGoogle Scholar
- Saito T, Deskin RW, Casola A, Häeberle H, Olszewska B, Ernst PB, Alarm R, Ogra PL, Garofalo L: Respiratory syncytial virus induces selective production of the chemokine RANTES by upper airway epithelial cells. J Infect Dis. 1997, 175: 497-504. 10.1093/infdis/175.3.497.View ArticlePubMedGoogle Scholar
- McNamara PS, Flanagan BF, Hart CA, Smyth RL: Production of chemokines in the lungs of infants with severe respiratory syncytial virus bronchiolitis. J Infect Dis. 2005, 191: 1225-1232. 10.1086/428855.View ArticlePubMedGoogle Scholar
- Greiff L, Venge P, Andersson M, Enander I, Linden M, Myint S, Persson CG: Effects of rhinovirus-induced common colds on granulocyte activity in allergic rhinitis. J Infect. 2002, 45: 227-232. 10.1053/jinf.2002.1063.View ArticlePubMedGoogle Scholar
- Message SD, Johnston SL: The immunology of virus infection in asthma. Eur Respir J. 2001, 18: 1013-1025. 10.1183/09031936.01.00228701.View ArticlePubMedGoogle Scholar
- Ball TM, Holberg CJ, Aldous MB, Martinez FD, Wright AL: Influence of attendance at day care on the common cold from birth through 13 years of age. Arch Pediatr Adolesc Med. 2002, 156: 121-126. 10.1001/archpedi.156.2.121.View ArticlePubMedGoogle Scholar
- Ciprandi G, Tosca MA, Fasce L: Allergic children have more numerous and severe respiratory infections than non-allergic children. Pediatr Allergy Immunol. 2006, 17: 389-391. 10.1111/j.1399-3038.2006.00413.x.View ArticlePubMedGoogle Scholar
- Bossuyt X, Moens L, Van Hoeyveld E, Jeurissen A, Bogaert G, Sauer K, Proesmans M, Raes M, De Boeck K: Coexistence of (partial) immune defects and risk of recurrent respiratory infections. Clin Chem. 2007, 53: 124-130.View ArticlePubMedGoogle Scholar
- Rossi GA, Peri C, Raynal ME, Defilippi AC, Risso FM, Schenone G, Pallestrini E, Melioli G: Naturally occurring immune response against bacteria commonly involved in upper respiratory tract infections: analysis of the antigen-specific salivary IgA levels. Immunol Lett. 2003, 86: 85-91. 10.1016/S0165-2478(02)00290-0.View ArticlePubMedGoogle Scholar
- Giagulli C, Noerder M, Avolio M, Becker PD, Fiorentini S, Guzman CA, Caruso A: Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level. Int Immunopharmacol. 2009, 9: 1366-1373. 10.1016/j.intimp.2009.08.010.View ArticlePubMedGoogle Scholar
- Reddel RR, Ke Y, Gerwin BI, McMenamin MG, Lechner JF, Su RT, Brash DE, Park JB, Rhim JS, Harris CC: Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-V40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 1988, 48: 1904-1909.PubMedGoogle Scholar
- Silvestri M, Serpero L, Petecchia L, Sabatini F, Cerasoli F, Rossi GA: Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide. Pulm Pharmacol Ther. 2006, 19: 210-217. 10.1016/j.pupt.2005.05.006.View ArticlePubMedGoogle Scholar
- Petecchia L, Sabatini F, Usai C, Caci E, Varesio L, Rossi GA: Cytokines induce tight junction disassembly in airway cells via an EGFR-dependent MAPK/ERK1/2-pathway. Lab Invest. 2012, 92: 1140-1148. 10.1038/labinvest.2012.67.View ArticlePubMedGoogle Scholar
- Donnelly RP, Crofford LJ, Freeman SL, Buras J, Remmers E, Wilder RL, Fenton MJ: Tissue-specific regulation of IL-6 production by IL-4. Differential effects of IL-4 on nuclear factor-kappa B activity in monocytes and fibroblasts. J Immunol. 1993, 151: 5603-5612.PubMedGoogle Scholar
- Riboldi P, Gerosa M, Meroni PL: Pidotimod: a reappraisal. Int J Immunopathol Pharmacol. 2009, 22: 255-262.PubMedGoogle Scholar
- Del-Rio-Navarro BE, Espinosa Rosales F, Flenady V, Sienra-Monge JJ: Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev. 2006, 4: CD004974-PubMedGoogle Scholar
- De la Torre GC, Pacheco Ríos A, Escalante Domínguez AJ, del Río Navarro BE: Comparative meta-analysis of immunoestimulant agents used in pediatric patients in Mexico. Rev Alerg Mex. 2005, 52: 25-38.Google Scholar
- Gern JE, Rosenthal LA, Sorkness RL, Lemanske RF: Effects of viral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol. 2005, 115: 668-674. 10.1016/j.jaci.2005.01.057.View ArticlePubMedGoogle Scholar
- Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J, Mclaughlin AP, Erwin EA, Shaker MS, Hellems M, Peerzada J, Hayden FG, Hatley TK, Chamberlain R: Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004, 114: 239-247. 10.1016/j.jaci.2004.04.006.View ArticlePubMedGoogle Scholar
- Oddera S, Silvestri M, Lantero S, Sacco O, Rossi GA: Downregulation of the expression of intercellular adhesion molecule (ICAM)-1 on bronchial epithelial cells by a beta2-adrenoceptor agonist: fenoterol. J Asthma. 1998, 35: 401-408. 10.3109/02770909809048948.View ArticlePubMedGoogle Scholar
- Papi A, Papadopoulos NG, Stanciu LA, Bellettato CM, Pinamonti S, Degitz K, Holgate ST, Johnston SL: Reducing agents inhibit rhinovirus-induced up-regulation of the rhinovirus receptor intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells. FASEB J. 2002, 16: 1934-1936.PubMedGoogle Scholar
- Kidney JC, Proud D: Neutrophil transmigration across human airway epithelial monolayers: mechanisms and dependence on electrical resistance. Am J Respir Cell Mol Biol. 2000, 23: 389-395. 10.1165/ajrcmb.23.3.4068.View ArticlePubMedGoogle Scholar
- Mulligan MS, Smith CW, Anderson DC, Todd RF, Miyasaka M, Tamatani T, Issekutz TB, Ward PA: Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol. 1993, 150: 2401-2406.PubMedGoogle Scholar
- Strieter RM, Kunkel SL: Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med. 1994, 42: 640-651.PubMedGoogle Scholar
- Everard ML, Swarbrick A, Wrightham M, McIntyre J, Dunkley C, James PD, Sewell HF, Milner AD: Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child. 1994, 71: 428-432. 10.1136/adc.71.5.428.PubMed CentralView ArticlePubMedGoogle Scholar
- Huang SH, Cao XJ, Liu W, Shi XY, Wei W: Inhibitory effect of melatonin on lung oxidative stress induced by respiratory syncytial virus infection in mice. J Pineal Res. 2010, 48: 109-116. 10.1111/j.1600-079X.2009.00733.x.View ArticlePubMedGoogle Scholar
- Othumpangat S, Regier M, Piedimonte G: Nerve growth factor modulates human rhinovirus infection in airway epithelial cells by controlling ICAM-1 expression. Am J Physiol Lung Cell Mol Physiol. 2012, 302: 1057-1066. 10.1152/ajplung.00365.2011.View ArticleGoogle Scholar
- Flo TH, Halaas O, Torp S, Ryan L, Lien E, Dybdahl B, Sundan A, Espevik T: Differential expression of Toll-like receptor 2 in human cells. J Leukoc Biol. 2001, 69: 474-481.PubMedGoogle Scholar
- Oh JH, Park EJ, Park JW, Lee J, Lee SH, Kwon TK: A novel cyclin-dependent kinase inhibitor down-regulates tumor necrosis factor-alpha (TNF-alpha)-induced expression of cell adhesion molecules by inhibition of NF-kappaB activation in human pulmonary epithelial cells. Int Immunopharmacol. 2010, 10: 572-579. 10.1016/j.intimp.2010.02.004.View ArticlePubMedGoogle Scholar
- Lin FS, Lin CC, Chien CS, Luo SF, Yang CM: Involvement of p42/p44 MAPK, JNK, and NF-kappaB in IL-1beta-induced ICAM-1 expression in human pulmonary epithelial cells. Cell Physiol. 2005, 202: 464-473. 10.1002/jcp.20142.View ArticleGoogle Scholar
- Talreja J, Kabir MH, B Filla M, Stechschulte DJ, Dileepan KN: Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components. Immunology. 2004, 113: 224-233. 10.1111/j.1365-2567.2004.01946.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Papon JF, Coste A, Gendron MC, Cordonnier C, Wingerstmann L, Peynègre R, Escudier E: HLA-DR and ICAM-1 expression and modulation in epithelial cells from nasal polyps. Laryngoscope. 2002, 112: 2067-2075. 10.1097/00005537-200211000-00030.View ArticlePubMedGoogle Scholar
- Gourgiotis D, Papadopoulos NG, Bossios A, Zamanis P, Saxoni-Papageorgiou P: Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children. J Asthma. 2004, 41: 285-287. 10.1081/JAS-120026085.View ArticlePubMedGoogle Scholar
- Akira S, Takeda K, Kaisho T: Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol. 2001, 2: 675-680. 10.1038/90609.View ArticlePubMedGoogle Scholar
- Akira S, Takeda K: Toll-like receptor signalling. Nat Rev Immunol. 2004, 4: 499-511. 10.1038/nri1391.View ArticlePubMedGoogle Scholar
- Ratner AJ, Bryan R, Weber A, Nguyen S, Barnes D, Pitt A, Gelber SE, Cheung A, Prince A: Cystic fibrosis pathogens activate Ca2+ dependent MAPK signaling pathways in airway epithelial cells. J Biol Chem. 2001, 276: 19267-19275. 10.1074/jbc.M007703200.View ArticlePubMedGoogle Scholar
- Wang T, Lafuse WP, Zwilling BS: Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol. 2000, 165: 6308-6313.View ArticlePubMedGoogle Scholar
- Wang T, Lafuse WP, Zwilling BS: NFkappaB and Sp1 elements are necessary for maximal transcription of toll-like receptor 2 induced by Mycobacterium avium. J Immunol. 2001, 167: 6924-6932.View ArticlePubMedGoogle Scholar
- Chang L, Karin M: Mammalian MAP kinase signalling cascades. Nature. 2001, 410: 37-40. 10.1038/35065000.View ArticlePubMedGoogle Scholar
- Agell N, Bachs O, Rocamora N, Villalonga P: Modulation of the Ras/Raf/MEK/ERK pathway by Ca2+, and calmodulin. Cell Signal. 2002, 14: 649-654. 10.1016/S0898-6568(02)00007-4.View ArticlePubMedGoogle Scholar
- Profita M, Sala A, Bonanno A, Siena L, Ferraro M, Di Giorgi R, Montalbano AM, D. Albano G, Gagliardo R, Gjomarkaj M: Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion. The American Society for Pharmacology and Experimental Therapeutics. 2008, 325: 1024-1030. 10.1124/jpet.107.131649.View ArticleGoogle Scholar
- Imasato A, Desbois-Mouthon C, Han J, Kai H, Cato AC, Akira S, Li JD: Inhibition of p38 MAPK by glucocorticoids via induction of MAPK phosphatase-1 enhances nontypeable Haemophilus influenzae-induced expression of toll-like receptor 2. J Biol Chem. 2002, 277: 47444-47450. 10.1074/jbc.M208140200.View ArticlePubMedGoogle Scholar
- Gilmore TD: Introduction to NF-kB: players, pathways, perspectives. Oncogene. 2006, 25: 6680-6684. 10.1038/sj.onc.1209954.View ArticlePubMedGoogle Scholar
- Brasier AR: The NF-kB regulatory network. Cardiovasc Toxicol. 2006, 6: 111-130. 10.1385/CT:6:2:111.View ArticlePubMedGoogle Scholar
- Perkins ND: Integrating cell-signalling pathways with NF-kB and IKK function. Nat Rev Mol Cell Biol. 2007, 8: 49-62. 10.1038/nrm2083.View ArticlePubMedGoogle Scholar
- Qin H, Wilson CA, Lee SJ, Zhao X, Benveniste EN: LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood. 2005, 106: 3114-3122. 10.1182/blood-2005-02-0759.PubMed CentralView ArticlePubMedGoogle Scholar
- Barnes PJ: Pathophysiology of allergic inflammation. Immunol Rev. 2011, 242: 31-50. 10.1111/j.1600-065X.2011.01020.x.View ArticlePubMedGoogle Scholar
- Cormet-Boyaka E, Jolivette K, Bonnegarde-Bernard A, Rennolds J, Hassan F, Mehta P, Tridandapani S, Webster-Marketon J, Boyaka PN: An NF-kB-independent and Erk1/2-dependent mechanism controls CXCL8/IL-8 responses of airway epithelial cells to cadmium. Toxicol Sci. 2012, 125: 418-429. 10.1093/toxsci/kfr310.PubMed CentralView ArticlePubMedGoogle Scholar
- Mio T, Romberger DJ, Thompson AB, Robbins RA, Heires A, Rennard SI: Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am J Respir Cri Care Med. 1997, 155: 1770-1776. 10.1164/ajrccm.155.5.9154890.View ArticleGoogle Scholar
- Witherden IR, Vanden Bon EJ, Goldstraw P, Ratcliffe C, Pastorino U, Tetley TD: Primary human alveolar type II epithelial cell chemokine release: effects of cigarette smoke and neutrophil elastase. Am J Respir Cell Mol Biol. 2004, 30: 500-509. 10.1165/rcmb.4890.View ArticlePubMedGoogle Scholar
- Rahman I, MacNee W: Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med. 2000, 28: 1405-1420. 10.1016/S0891-5849(00)00215-X.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.